Moxibustion powder for treating chronic obstructive pulmonary disease as well as preparation method and application of moxibustion powder
A technology for chronic obstructive pulmonary disease, used in respiratory diseases, medical preparations containing active ingredients, powder delivery, etc., can solve problems such as unsuitable long-term use, large side effects of chemical drugs and hormones, and reduced patient compliance.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0035] Embodiment 1: moxibustion powder of the present invention
[0036] Weigh 10g of red ginseng, 15g of Agrimony, 7g of Chuan Fritillaria, 15g of perilla seeds, 15g of fried Tinglizi, 15g of white mustard seeds, 15g of psoralen, 10g of sandalwood, 9g of orange red, 15g of red peony, and male clove 8g, 15g cinnamon, 1g musk, placed in a microwave oven for 2 minutes, dried, crushed through a 100-mesh sieve, put into a glass container and sealed for later use;
[0037] Grind Chen AI over 5 years into fine powder, pass through a 100-mesh sieve, put it into a glass container and seal it for later use;
[0038] Mix the traditional Chinese medicine powder prepared above and 10 g of moxibustion powder, add 10 g of volatile oil of Semen Nigellae, a vitamin medicine, and stir well to obtain the moxibustion powder.
Embodiment 2
[0039] Embodiment 2: compare with the curative effect of different compound prescriptions
[0040] Case selection: 80 patients were selected in each group, and the diagnosis met the criteria stipulated in the "Guidelines for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2013 Revision)" promulgated by the Chronic Obstructive Pulmonary Disease Group of the Respiratory Disease Branch of the Chinese Medical Association in 2013. The selected cases were all in the acute attack stage, not combined with other extrapulmonary diseases, and did not use theophylline drugs and systemic corticosteroids within 1 week. Among the 80 patients, there were 50-55 males and 25-30 females, aged 46.1-88.2 years old, with an average of 65.4±22.1 years old. The selected cases were excluded: hormone dependent persons, patients with severe heart, liver, renal insufficiency and acute myocardial infarction, pregnant women and lactating women.
[0041] Treatment method: When each group ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Mesh | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More